doi: 10.3967/bes2024.090
The Regulatory Role and Mechanism of Circadian Rhythm in Hemoglobin Co-cultured Neurovascular Unit
-
Abstract:
Objective Intracranial hemorrhage (ICH), the second most common subtype of stroke, exacerbates the disruption of the blood-brain barrier (BBB), leading to vasogenic edema, plasma protein extravasation, and infiltration of neurotoxic substances. The clearance capacity of the brain plays a crucial role in maintaining BBB homeostasis and facilitating patient recovery after hemorrhage. This study aimed to investigate the effect of circadian rhythms on BBB function, neuronal damage, and clearance capabilities. Methods The transwell model and hemoglobin were co-cultured to simulate the BBB environment after ICH. After intervention with different light groups, neuronal apoptosis was determined, glial phagocytosis was analyzed, the expression of endogenous clearing-related proteins aquaporin 4 (AQP4) and low-density lipoprotein receptor-related protein 1 (LRP1) was detected by western blotting and immunofluorescence dual standard method, and the expression of the tight junction protein occludin and melatonin receptor 1A (MTNR1A) was quantitatively analyzed. Results Circadian rhythms play a key role in maintaining the integrity of the BBB, reducing oxidative stress-induced neuronal damage, and improving microglial phagocytosis. Meanwhile, the expression of occludin and MTNR1A in neurovascular unit (NVU) co-cultured with hemoglobin improved the expression of AQP4 and LRP1, the key proteins in the NVU’s endogenous brain clearance system. Conclusion Circadian rhythm (alternating black and white light) protects the NVU BBB function after ICH, promotes the expression of proteins related to the clearance of the hematoma, provides new evidence for the clinical treatment of patients recovering from ICH, and improves the circadian rhythm to promote brain metabolism and hematoma clearance. -
Key words:
- Blood-brain barrier /
- Circadian rhythm /
- Neurovascular unit /
- Melatonin receptor 1A /
- Aquaporin-4
-
Figure 2. Functional features of the in vitro neurovascular unit (NVU) model. (A) Four-cell morphologies for the establishment of an in vitro NVU model. (B) Immunostaining for all cell types in the NVU model. Brain microvascular endothelial cells (BMECs) are stained for von Willebrand factor (vWF), astrocytes stained for glial fibrillary acidic protein (GFAP), neurons stained for Tubulin and microglial cells stained for CD11b. (C) Transendothelial electrical resistance (TEER) values for 7 days. (D) The permeability coefficient of sodium fluorescein in the B+N+A+M, B+M, B+A, B+N, and B groups. B+N+A+M group: BMECs cultured with neurons, astrocytes, and microglial cells; B+M group: BMECs cultured with microglial cells; B+A group: BMECs cultured with astrocytes; B+N group: BMECs cultured with neurons; B group: BMECs cultured alone in the transwell chamber. Data are expressed as mean ± SD. **P < 0.01, ***P < 0.001.
Figure 3. neurovascular unit (NVU) barrier function co-cultured with hemoglobin under different illumination. (A) The TEER values in the alternating black and white light, dark, white light, and blue light groups. (B) The permeability coefficient of sodium fluorescein in the alternating black and white light, dark, white light, and blue light groups. Data are expressed as mean ± SD. **P < 0.01, ***P < 0.001, ****P < 0.0001.
Figure 4. Neuron damage and microglia phagocytosis decreased in neurovascular unit (NVU) co-cultured with hemoglobin under different illumination. (A) The neuron survival rate in the alternating black and white light, dark, white light, and blue light groups. (B) Neuron oxidative stress injury in the alternating black and white light, dark, white light, and blue light groups. (C) The apoptosis rate of neurons in the alternating black and white light, dark, white light, and blue light groups. (D) Microglial phagocytosis in the alternating black and white light, dark, white light, and blue light groups. Data are expressed as mean ± SD. **P < 0.01, ***P < 0.001, ****P < 0.0001.
Figure 5. The expression of occludin and MTNR1A in neurovascular unit (NVU) co-cultured with hemoglobin under different illumination. (A, B) Western blot and quantification of occludin and MTNR1A in the alternating black and white light, dark, white light, and blue light groups, with β-actin as endogenous control. (C) Immunofluorescent staining of occludin and MTNR1A in the alternating black and white light, dark, white light, and blue light groups. Data are expressed as mean ± SD. **P < 0.01, ***P < 0.001, ****P < 0.0001.
Figure 6. The expression of AQP4 and LRP1 in NVU co-cultured with hemoglobin under different illumination. (A, B) Western blot and quantification of AQP4 and LRP1 in the alternating black and white light, dark, white light, and blue light groups, with β-actin as endogenous control. (C) Immunofluorescent staining of AQP4 and LRP1 in the alternating black and white light, dark, white light, and blue light groups. aquaporin 4; LRP1, lipoprotein receptor-related protein 1.
-
[1] Owolabi MO, Thrift AG, Mahal A, et al. Primary stroke prevention worldwide: translating evidence into action. Lancet Public Health, 2022; 7, e74−85. doi: 10.1016/S2468-2667(21)00230-9 [2] Saldana S, Breslin J, Hanify J, et al. Comparison of clevidipine and nicardipine for acute blood pressure reduction in hemorrhagic stroke. Neurocrit Care, 2022; 36, 983−92. doi: 10.1007/s12028-021-01407-w [3] Xiao MJ, Xiao ZJ, Yang BB, et al. Blood-brain barrier: more contributor to disruption of central nervous system homeostasis than victim in neurological disorders. Front Neurosci, 2020; 14, 764. doi: 10.3389/fnins.2020.00764 [4] Cui Y, Zhao Y, Chen SY, et al. Association of serum biomarkers with post-thrombolytic symptomatic intracranial hemorrhage in stroke: a comprehensive protein microarray analysis from INTRECIS study. Front Neurol, 2022; 13, 751912. doi: 10.3389/fneur.2022.751912 [5] Schaeffer S, Iadecola C. Revisiting the neurovascular unit. Nat Neurosci, 2021; 24, 1198−209. doi: 10.1038/s41593-021-00904-7 [6] McConnell HL, Mishra A. Cells of the blood-brain barrier: an overview of the neurovascular unit in health and disease. In: Stone N. The Blood-Brain Barrier: Methods and Protocols. Humana. 2022, 3-24. [7] Dormanns K, Brown RG, David T. Neurovascular coupling: a parallel implementation. Front Comput Neurosci, 2015; 9, 109. [8] Iadecola C. The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron, 2017; 96, 17−42. doi: 10.1016/j.neuron.2017.07.030 [9] Liu JC, Guo YZ, Zhang CY, et al. Clearance systems in the brain, from structure to function. Front Cell Neurosci, 2022; 15, 729706. doi: 10.3389/fncel.2021.729706 [10] Nedergaard M, Goldman SA. Glymphatic failure as a final common pathway to dementia. Science, 2020; 370, 50−6. doi: 10.1126/science.abb8739 [11] Rasmussen MK, Mestre H, Nedergaard M. The glymphatic pathway in neurological disorders. Lancet Neurol, 2018; 17, 1016−24. doi: 10.1016/S1474-4422(18)30318-1 [12] Kitchen P, Salman MM, Halsey AM, et al. Targeting aquaporin-4 subcellular localization to treat central nervous system edema. Cell, 2020; 181, 784-99. e19. [13] Qing WG, Dong YQ, Ping TQ, et al. Brain edema after intracerebral hemorrhage in rats: the role of iron overload and aquaporin 4. J Neurosurg, 2009; 110, 462−8. doi: 10.3171/2008.4.JNS17512 [14] Wang GQ, Manaenko A, Shao AW, et al. Low-density lipoprotein receptor-related protein-1 facilitates heme scavenging after intracerebral hemorrhage in mice. J Cereb Blood Flow Metab, 2017; 37, 1299−310. doi: 10.1177/0271678X16654494 [15] Wang GQ, Guo ZN, Tong LS, et al. TLR7 (toll-like receptor 7) facilitates heme scavenging through the BTK (Bruton tyrosine kinase)-CRT (calreticulin)-LRP1 (low-density lipoprotein receptor-related protein-1)-Hx (hemopexin) pathway in murine intracerebral hemorrhage. Stroke, 2018; 49, 3020−9. doi: 10.1161/STROKEAHA.118.022155 [16] Mitchell JW, Gillette MU. Development of circadian neurovascular function and its implications. Front Neurosci, 2023; 17, 1196606. doi: 10.3389/fnins.2023.1196606 [17] Hablitz LM, Plá V, Giannetto M, et al. Circadian control of brain glymphatic and lymphatic fluid flow. Nat Commun, 2020; 11, 4411. doi: 10.1038/s41467-020-18115-2 [18] Cardinali DP. Melatonin and healthy aging. Vitam Horm, 2021; 115, 67−88. [19] Wahl S, Engelhardt M, Schaupp P, et al. The inner clock-blue light sets the human rhythm. J Biophotonics, 2019; 12, e201900102. doi: 10.1002/jbio.201900102 [20] Xue Q, Liu Y, Qi HY, et al. A novel brain neurovascular unit model with neurons, astrocytes and microvascular endothelial cells of rat. Int J Biol Sci, 2013; 9, 174−89. doi: 10.7150/ijbs.5115 [21] Li CX, Wang XQ, Cheng FF, et al. Hyodeoxycholic acid protects the neurovascular unit against oxygen-glucose deprivation and reoxygenation-induced injury in vitro. Neural Regen Res, 2019; 14, 1941−9. doi: 10.4103/1673-5374.259617 [22] Keep RF, Andjelkovic AV, Xiang JM, et al. Brain endothelial cell junctions after cerebral hemorrhage: changes, mechanisms and therapeutic targets. J Cereb Blood Flow Metab, 2018; 38, 1255−75. doi: 10.1177/0271678X18774666 [23] Stokum JA, Gerzanich V, Simard JM. Molecular pathophysiology of cerebral edema. J Cereb Blood Flow Metab, 2016; 36, 513−38. doi: 10.1177/0271678X15617172 [24] Chen SP, Li LZ, Peng C, et al. Targeting oxidative stress and inflammatory response for blood-brain barrier protection in intracerebral hemorrhage. Antioxid Redox Signal, 2022; 37, 115−34. doi: 10.1089/ars.2021.0072 [25] Da Mesquita S, Papadopoulos Z, Dykstra T, et al. Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy. Nature, 2021; 593, 255−60. doi: 10.1038/s41586-021-03489-0 [26] Liu LR, Liu JC, Bao JS, et al. Interaction of microglia and astrocytes in the neurovascular unit. Front Immunol, 2020; 11, 1024. doi: 10.3389/fimmu.2020.01024 [27] Tiret P, Chaigneau E, Lecoq J, et al. Two-photon imaging of capillary blood flow in olfactory bulb glomeruli. In: Hyder F. Dynamic Brain Imaging: Multi-Modal Methods and In Vivo Applications. Humana. 2009, 81-91. [28] LeDoux JE, Thompson ME, Iadecola C, et al. Local cerebral blood flow increases during auditory and emotional processing in the conscious rat. Science, 1983; 221, 576−8. doi: 10.1126/science.6867731 [29] Zhang WJ, Zhao XJ, Qi XW, et al. Induced pluripotent stem cell model revealed impaired neurovascular interaction in genetic small vessel disease cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Front Cell Neurosci, 2023; 17, 1195470. doi: 10.3389/fncel.2023.1195470 [30] Wang C, Gu W, Zhao K, et al. A new neurotoxicity model composed of a neurovascular unit in vitro. Cell Mol Biol, 2016; 62, 21−6. doi: 10.14715/cmb/2016.62.13.5 [31] Greco CM, Sassone-Corsi P. Circadian blueprint of metabolic pathways in the brain. Nat Rev Neurosci, 2019; 20, 71−82. [32] Neves AR, Albuquerque T, Quintela T, et al. Circadian rhythm and disease: relationship, new insights, and future perspectives. J Cell Physiol, 2022; 237, 3239−56. doi: 10.1002/jcp.30815 [33] Deaver JA, Eum SY, Toborek M. Circadian disruption changes gut microbiome taxa and functional gene composition. Front Microbiol, 2018; 9, 737. doi: 10.3389/fmicb.2018.00737 [34] Kress GJ, Liao F, Dimitry J, et al. Regulation of amyloid-β dynamics and pathology by the circadian clock. J Exp Med, 2018; 215, 1059−68. doi: 10.1084/jem.20172347 [35] Yang DF, Huang WC, Wu CW, et al. Acute sleep deprivation exacerbates systemic inflammation and psychiatry disorders through gut microbiota dysbiosis and disruption of circadian rhythms. Microbiol Res, 2023; 268, 127292. doi: 10.1016/j.micres.2022.127292 [36] Kawaguchi C, Shintani N, Hayata-Takano A, et al. Lipocalin-type prostaglandin D synthase regulates light-induced phase advance of the central circadian rhythm in mice. Commun Biol, 2020; 3, 557. doi: 10.1038/s42003-020-01281-w [37] Zhang SL, Yue ZF, Arnold DM, et al. A circadian clock in the blood-brain barrier regulates xenobiotic efflux. Cell, 2018; 173, 130-9. e10. [38] Lan X, Han XN, Li Q, et al. (−)-Epicatechin, a natural flavonoid compound, protects astrocytes against hemoglobin toxicity via Nrf2 and AP-1 signaling pathways. Mol Neurobiol, 2017; 54, 7898−907. doi: 10.1007/s12035-016-0271-y [39] Li Q, Lan X, Han XN, et al. Microglia-derived interleukin-10 accelerates post-intracerebral hemorrhage hematoma clearance by regulating CD36. Brain Behav Immun, 2021; 94, 437−57. doi: 10.1016/j.bbi.2021.02.001 [40] Feldman GJ, Mullin JM, Ryan MP. Occludin: structure, function and regulation. Adv Drug Deliv Rev, 2005; 57, 883−917. doi: 10.1016/j.addr.2005.01.009 [41] Spinedi E, Cardinali DP. Neuroendocrine-metabolic dysfunction and sleep disturbances in neurodegenerative disorders: focus on Alzheimer's disease and melatonin. Neuroendocrinology, 2019; 108, 354−64. doi: 10.1159/000494889 [42] Li YM, Zhang J, Wan JL, et al. Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: a potential therapeutic molecule for Alzheimer's disease. Biomed Pharmacother, 2020; 132, 110887. doi: 10.1016/j.biopha.2020.110887 [43] Zhao ZA, Li P, Ye SY, et al. Perivascular AQP4 dysregulation in the hippocampal CA1 area after traumatic brain injury is alleviated by adenosine A2A receptor inactivation. Sci Rep, 2017; 7, 2254. doi: 10.1038/s41598-017-02505-6 [44] Semyachkina-Glushkovskaya OV, Karavaev AS, Prokhorov MD, et al. EEG biomarkers of activation of the lymphatic drainage system of the brain during sleep and opening of the blood-brain barrier. Comput Struct Biotechnol J, 2023; 21, 758−68. doi: 10.1016/j.csbj.2022.12.019 [45] Ma QY, Zhao Z, Sagare AP, et al. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Mol Neurodegener, 2018; 13, 57. doi: 10.1186/s13024-018-0286-0 [46] Wang GQ, Li T, Duan SN, et al. PPAR-γ promotes hematoma clearance through haptoglobin-hemoglobin-CD163 in a rat model of intracerebral hemorrhage. Behav Neurol, 2018; 2018, 7646104. -
24041NEW+Supplementary Materials.pdf